MENU
+Compare
UTHR
Stock ticker: NASDAQ
AS OF
Jun 5, 04:59 PM (EDT)
Price
$319.90
Change
-$4.07 (-1.26%)
Capitalization
14.61B

UTHR United Therapeutics Corp Forecast, Technical & Fundamental Analysis

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs... Show more

UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for UTHR with price predictions
Jun 04, 2025

UTHR in upward trend: 10-day moving average crossed above 50-day moving average on May 15, 2025

The 10-day moving average for UTHR crossed bullishly above the 50-day moving average on May 15, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 15, 2025. You may want to consider a long position or call options on UTHR as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

UTHR moved above its 50-day moving average on May 15, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UTHR advanced for three days, in of 314 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 259 cases where UTHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for UTHR moved out of overbought territory on June 03, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UTHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

UTHR broke above its upper Bollinger Band on June 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UTHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.147) is normal, around the industry mean (16.306). P/E Ratio (12.907) is within average values for comparable stocks, (59.921). Projected Growth (PEG Ratio) (0.734) is also within normal values, averaging (2.224). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (5.219) is also within normal values, averaging (265.014).

View a ticker or compare two or three
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

UTHR is expected to report earnings to rise 10.86% to $7.35 per share on July 30

United Therapeutics Corp UTHR Stock Earnings Reports
Q2'25
Est.
$7.35
Q1'25
Beat
by $0.10
Q4'24
Missed
by $0.49
Q3'24
Missed
by $0.14
Q2'24
Missed
by $0.63
The last earnings report on April 30 showed earnings per share of $6.63, beating the estimate of $6.53. With 151.93K shares outstanding, the current market capitalization sits at 14.61B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
UFT.X0.0070360.000090
+1.30%
UniLend cryptocurrency
QTUM.X2.043749-0.038459
-1.85%
Qtum cryptocurrency
CHR.X0.085162-0.002237
-2.56%
Chromia cryptocurrency
APT.X4.792617-0.143427
-2.91%
Aptos cryptocurrency
LOKA.X0.057182-0.002090
-3.53%
League of Kingdoms Arena cryptocurrency

UTHR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with DAWN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then DAWN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
-0.07%
DAWN - UTHR
41%
Loosely correlated
-0.72%
VKTX - UTHR
35%
Loosely correlated
+1.47%
GERN - UTHR
35%
Loosely correlated
-1.91%
TECH - UTHR
34%
Loosely correlated
+2.19%
ROIV - UTHR
34%
Loosely correlated
-0.31%
More

Groups containing UTHR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
-0.07%
Pharmaceuticals
category (298 stocks)
28%
Poorly correlated
-0.33%